+ All Categories
Home > Presentations & Public Speaking > Pharma forum 2016 by Maharshi Mehta

Pharma forum 2016 by Maharshi Mehta

Date post: 08-Jan-2017
Category:
Upload: kartik-vora
View: 172 times
Download: 1 times
Share this document with a friend
35
www.issehs.com Analysis of Exposure Monitoring Analysis of Exposure Monitoring Results and Lessons Learned – Results and Lessons Learned – Pharmaceutical Unit Operations Pharmaceutical Unit Operations Maharshi Mehta, CSP, CIH Maharshi Mehta, CSP, CIH Prasanth K., CIH, Gopal C. Prasanth K., CIH, Gopal C. International Safety Systems, Inc. International Safety Systems, Inc. 1 Pharma Forum 2016 Pharma Forum 2016 AIHCE, Baltimore, May 25 AIHCE, Baltimore, May 25
Transcript
Page 1: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Analysis of Exposure Monitoring Results and Analysis of Exposure Monitoring Results and Lessons Learned – Pharmaceutical Unit Lessons Learned – Pharmaceutical Unit OperationsOperations

Maharshi Mehta, CSP, CIHMaharshi Mehta, CSP, CIHPrasanth K., CIH, Gopal C.Prasanth K., CIH, Gopal C.International Safety Systems, Inc.International Safety Systems, Inc.

11

Pharma Forum 2016Pharma Forum 2016AIHCE, Baltimore, May 25AIHCE, Baltimore, May 25

Page 2: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

ObjectivesObjectives

Analyze API and surrogate monitoring results Analyze API and surrogate monitoring results Identify exposures at unit operations Identify exposures at unit operations Identify effectiveness of exposure controls Identify effectiveness of exposure controls Identify exposure contributory factorsIdentify exposure contributory factors Reduce future exposure monitoring Reduce future exposure monitoring Implement exposure controls based on lessons learned Implement exposure controls based on lessons learned

22

This study is beginning of long term study of 10000+ sampling results

Page 3: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Results OriginResults Origin

~ 5500 results of API and surrogates~ 5500 results of API and surrogates 100+ workplaces 100+ workplaces 21+ countries21+ countries Over a period of last 7 years Over a period of last 7 years Personal and area sampling Personal and area sampling APIs and surrogates APIs and surrogates Only air samples considered, not wipe Only air samples considered, not wipe 11 ISS professionals were involved in collecting data11 ISS professionals were involved in collecting data Only ISS collected data is considered at this time Only ISS collected data is considered at this time

33

www.issehs.com

Page 4: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

USAUSA CanadaCanada Mexico Mexico BrazilBrazil ColumbiaColumbia Argentina Argentina

Results Origin: AmericasResults Origin: Americas

Page 5: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Results Origin : AsiaResults Origin : Asia

IndiaIndia China China SingaporeSingapore IndonesiaIndonesia JapanJapan Australia Australia

Page 6: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Austria Austria Germany Germany Netherland Netherland France France Ireland Ireland Portugal Portugal Italy Italy Spain Spain UKUK

Results Origin: EuropeResults Origin: Europe

Page 7: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Challenges Challenges

Result variability – GSD Result variability – GSD Work practices dependent Work practices dependent Engineering controls and particulate Engineering controls and particulate

containment variability containment variability Weight of API/surrogateWeight of API/surrogate

77

Page 8: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Methods – API/Surrogate Sampling Methods – API/Surrogate Sampling and Analysisand Analysis Only validated methods from AIHA accredited lab with Only validated methods from AIHA accredited lab with

pharma analytical expertise used and anlyzedpharma analytical expertise used and anlyzed Written protocol for sampling used Written protocol for sampling used

– Sample flow rates/volumeSample flow rates/volume– MediaMedia– Avoiding cross contamination Avoiding cross contamination – Each sample in zip-lock plastic bag Each sample in zip-lock plastic bag

ISPE protocol used for surrogate monitoring ISPE protocol used for surrogate monitoring

88

Page 9: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Method – Data Analysis Method – Data Analysis

Sampling notes entered in result sheets in Excel® was Sampling notes entered in result sheets in Excel® was available workplacesavailable workplaces

Result sheets were standardized Result sheets were standardized – Sample id, Sample id, – Sample duration, Sample duration, – Unit OperationsUnit Operations– Weight of API/SurrogateWeight of API/Surrogate– Controls provided Controls provided

Results were sortedResults were sorted

99

Page 10: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Unit operations for statistical Unit operations for statistical analysesanalyses As a first stage of the analysis, unit operations with less As a first stage of the analysis, unit operations with less

variability selected variability selected – Laboratory scale weighing with controls (VBSE, or laboratory Laboratory scale weighing with controls (VBSE, or laboratory

fume hoods) and without controlsfume hoods) and without controls– Weighing dispensing in isolatorWeighing dispensing in isolator– Charging/discharging with split butterfly valveCharging/discharging with split butterfly valve– Weighing and dispensing in Laminar Flow BoothWeighing and dispensing in Laminar Flow Booth– QC samplingQC sampling

500 + results separated for above unit operations and for 500 + results separated for above unit operations and for weight of API/surrogate weight of API/surrogate

1010

Page 11: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Statistical Analysis Tool usedStatistical Analysis Tool used

IHSTAT®IHSTAT®– From AIHA Exposure Assessment CommitteeFrom AIHA Exposure Assessment Committee

IHData Analyst® (Bayesian Data Analysis)IHData Analyst® (Bayesian Data Analysis) Results for the unit operations were entered Results for the unit operations were entered Results were separated for weight range Results were separated for weight range 9595thth%tile point estimate and GSD were determine %tile point estimate and GSD were determine Lognormal distribution was determinedLognormal distribution was determined

1111

Page 12: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Results and preliminary Results and preliminary conclusions – Qualifiers conclusions – Qualifiers The results are indicative and not confirmative The results are indicative and not confirmative The conclusion from the results and lessons learned are The conclusion from the results and lessons learned are

also indicative and not confirmativealso indicative and not confirmative Additional study is neededAdditional study is needed

1212

Page 13: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Personal exposure: Laboratory Scale Personal exposure: Laboratory Scale weighing in VBSEweighing in VBSE

Sample size: 10Sample size: 10 Range of results: < 0.04 – 0.41 Range of results: < 0.04 – 0.41 μμg/mg/m33 Sample Duration: 27 - 34 MinutesSample Duration: 27 - 34 Minutes Sample Weight: < 1 gramSample Weight: < 1 gram GSD: 2.59GSD: 2.59 9595thth%ile – 1.57 %ile – 1.57 μμg/mg/m33 Lognormal distribution hypothesis is not Lognormal distribution hypothesis is not

rejectedrejected

1313

Page 14: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Personal exposure: Laboratory Personal exposure: Laboratory weighing- no exposure controls weighing- no exposure controls

Sample size: 12 Sample size: 12 Range of results: 0.078 – 3.84 Range of results: 0.078 – 3.84 μμg/mg/m33 Sample Duration: 5 – 15 minutesSample Duration: 5 – 15 minutes Sample Weight: < 1 gramSample Weight: < 1 gram GSD – 4.48GSD – 4.48 9595thth%ile – 4.21 %ile – 4.21 μμg/mg/m33 Lognormal distribution hypothesis is not Lognormal distribution hypothesis is not

rejectedrejected

1414

Page 15: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Comparison of laboratory scale weighing Comparison of laboratory scale weighing resultsresults

1515

Page 16: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Lessons Learned-Laboratory Lessons Learned-Laboratory WeighingWeighing Initial Indication – For < grams of weighingInitial Indication – For < grams of weighing

– OEB 5 (< ug/mOEB 5 (< ug/m33) and low OEB 4 (>1 ug/m3 and < 10 ug/m) and low OEB 4 (>1 ug/m3 and < 10 ug/m33) compounds ) compounds may require isolator may require isolator

– VBE could be used for OEB 4 compounds coupled with sound work-practices VBE could be used for OEB 4 compounds coupled with sound work-practices and PPEand PPE

Work-practices contributing to high exposuresWork-practices contributing to high exposures– Using brush to clean surfacesUsing brush to clean surfaces– Removing API container and other tools out without wipe cleaning and Removing API container and other tools out without wipe cleaning and

without double plastic bags without double plastic bags All size and types of enclosures are used – use only VBSE that All size and types of enclosures are used – use only VBSE that

meets specifications meets specifications – HEPA filterHEPA filter– Port for removal of waste Port for removal of waste

1616

Page 17: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Personal exposure: Dispensing inside Isolator Personal exposure: Dispensing inside Isolator (Weight Range 20 Kg – 40 Kg)(Weight Range 20 Kg – 40 Kg)

1717

Sample size: 16 Sample size: 16 Range of results: 0.025 Range of results: 0.025 μμg/mg/m33 – –

4.6 4.6 μμg/mg/m33 Sample Duration: 30 – 60 minutesSample Duration: 30 – 60 minutes Sample Weight : 20 – 40 Kg’s Sample Weight : 20 – 40 Kg’s GSD: 4.3GSD: 4.3 9595thth%ile exposure: 3.15 %ile exposure: 3.15 μμg/mg/m33

Lognormal distribution hypothesis Lognormal distribution hypothesis is not rejectedis not rejected

Page 18: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Between the two glove ports of main dispensing Between the two glove ports of main dispensing chamber (Weight range: 20 – 40 Kg)chamber (Weight range: 20 – 40 Kg)

Sample size: 9 Sample size: 9 Range of results: < 0.004 Range of results: < 0.004 μμg/mg/m33 – –

0.58 0.58 μμg/mg/m33 Sample Duration: 30 – 60 minutesSample Duration: 30 – 60 minutes Sample Weight : 20 – 40 Kg Sample Weight : 20 – 40 Kg GSD: 3.84GSD: 3.84 9595thth%ile: 1.62 %ile: 1.62 μμg/mg/m33 Lognormal distribution hypothesis Lognormal distribution hypothesis

is not rejectedis not rejected

1818

Page 19: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Adjacent to RTP/Pass box (Weight range: 20 Adjacent to RTP/Pass box (Weight range: 20 Kg – 40 Kg) Kg – 40 Kg)

1919

Sample size: 18 Sample size: 18 Range of results: 0.055 Range of results: 0.055

μμg/mg/m33 – 2.43 – 2.43 μμg/mg/m33 Sample Duration: 30 – 60 Sample Duration: 30 – 60

minutesminutes Sample Weight : 20 – 40 KgSample Weight : 20 – 40 Kg GSD: 2.9GSD: 2.9 9595thth%ile: 1.88 %ile: 1.88 μμg/mg/m33 Lognormal distribution Lognormal distribution

hypothesis is not rejectedhypothesis is not rejected

Page 20: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

9595thth%ile for Dispensing inside Isolator (for %ile for Dispensing inside Isolator (for weight range of 20-40 Kg)weight range of 20-40 Kg)

2020

Page 21: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Lessons Learned-Isolator Lessons Learned-Isolator

Do not assume exposure will be below OEB 4-5 APIs as isolator Do not assume exposure will be below OEB 4-5 APIs as isolator is used. is used.

Best of isolator would not reduce exposures if work practices are Best of isolator would not reduce exposures if work practices are not followed:not followed:– API container when received has no contamination outside?API container when received has no contamination outside?– In double plastic bags?In double plastic bags?– Isolator integrity test before being used?Isolator integrity test before being used?– Make-shift or real isolator?Make-shift or real isolator?– Disposable spatula and tools used? Wiped and in double plastic bags Disposable spatula and tools used? Wiped and in double plastic bags

before removing?before removing? Develop detailed SOP on selecting, validating and using isolatorDevelop detailed SOP on selecting, validating and using isolator

2121

Page 22: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Personal Exposure: Charging/Discharging Personal Exposure: Charging/Discharging using SBV (15 Kg – 60 Kg)using SBV (15 Kg – 60 Kg)

Sample size: 21Sample size: 21 Results range: 0.028 Results range: 0.028 μμg/mg/m33 - - 4.264.26

μμg/mg/m33 SSample Duration: 30 – 90 ample Duration: 30 – 90

minutesminutes Sample Weight: 15 kg – 60 kg Sample Weight: 15 kg – 60 kg GSD : 4.17GSD : 4.17 9595thth %ile : 7.69 %ile : 7.69 μμg/mg/m33 Lognormal distribution hypothesis is Lognormal distribution hypothesis is

not rejectednot rejected

2222

Page 23: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Area Sample: Charging (weight range: 15 Kg – Area Sample: Charging (weight range: 15 Kg – 60 Kg)60 Kg)

Sample size: 44Sample size: 44 Results range: 0.032 – 21.6 Results range: 0.032 – 21.6 μμg/mg/m33 SSample Duration: 30 – 90 minutesample Duration: 30 – 90 minutes Sample Weight 15 kg – 60 kg Sample Weight 15 kg – 60 kg GSD: 3.7GSD: 3.7 9595thth %%ile: 3.53 ile: 3.53 μμg/mg/m33

Lognormal distribution hypothesis is Lognormal distribution hypothesis is not rejectednot rejected

2323

Page 24: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

9595thth %ile results: Charging with SBV %ile results: Charging with SBV

2424

Page 25: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Lessons Learned - Lessons Learned - SBVSBV

Don not assume installation of SBV will reduce Don not assume installation of SBV will reduce particulate emissions below OEB 4/5 OELs. particulate emissions below OEB 4/5 OELs.

Selection, installation, use/misuse and maintenance of Selection, installation, use/misuse and maintenance of SBV resulted in to high area concentrationsSBV resulted in to high area concentrations

Carefully select supplier – initial cost may be high – long Carefully select supplier – initial cost may be high – long term cost savings and exposure reduction benefits could term cost savings and exposure reduction benefits could be significantbe significant

2525

Page 26: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Personal exposure: API Dispensing Inside Personal exposure: API Dispensing Inside LFB (LFB (Weight: 500 grams – 1.5 kg ) Weight: 500 grams – 1.5 kg )

2626

Sample size: 14Sample size: 14 Results range: 0.077 Results range: 0.077 μμg/mg/m33 - - 128128

μμg/mg/m33 SSample Duration: 15 – 60 min.ample Duration: 15 – 60 min. Sample GSD : 7.09Sample GSD : 7.09 9595thth %tile : 94 %tile : 94 μμg/mg/m33 Lognormal distribution hypothesis

is not rejected

Page 27: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Personal exposure: API QC sampling inside Personal exposure: API QC sampling inside LFB (60 grams) (results from single site)LFB (60 grams) (results from single site)

Sample size: 14Sample size: 14 Results range: 0.108 Results range: 0.108 μμg/mg/m33 – 15.9 – 15.9 μμg/mg/m33 SSample Duration: 15 – 30 minutesample Duration: 15 – 30 minutes GSD : 5.11GSD : 5.11 9595thth %ile: 21.1 %ile: 21.1 μμg/mg/m33 Lognormal distribution hypothesis is Lognormal distribution hypothesis is

not rejectednot rejected

2727

Page 28: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Personal exposure: API QC sampling inside Personal exposure: API QC sampling inside LFB (10-100 grams) – Multiple site dataLFB (10-100 grams) – Multiple site data

Sample size: 23Sample size: 23 Results range: 0.108 Results range: 0.108 μμg/mg/m33 – 196 – 196 μμg/mg/m33 SSample Duration: 15 – 30 minutesample Duration: 15 – 30 minutes GSD : 8.05GSD : 8.05 9595thth %ile: 147 %ile: 147 μμg/mg/m33 Lognormal distribution hypothesis is Lognormal distribution hypothesis is

not rejectednot rejected

2828

Page 29: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Lessons Learned during Lessons Learned during Dispensing/QC sampling under LFBDispensing/QC sampling under LFB

Focus on QC sampling same or even more than weighing and Focus on QC sampling same or even more than weighing and dispensingdispensing– Although API weight sampled is much lower than Although API weight sampled is much lower than

weighing/dispensing, exposure is likely to be highweighing/dispensing, exposure is likely to be high– Opening of containers for sampling – opening and closing of poly Opening of containers for sampling – opening and closing of poly

bag and breathing zone near bags during QC samplingbag and breathing zone near bags during QC sampling– Standardization of exposure controls (LFB) is important

What pharma IH community believed is confirmed What pharma IH community believed is confirmed – API exposure is not likely to be below < 50 API exposure is not likely to be below < 50 μμg/mg/m33 during during

weighing/dispensing in LFBweighing/dispensing in LFB– Work practices significantly contribute to higher exposuresWork practices significantly contribute to higher exposures

2929

Page 30: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Summary: 95Summary: 95thth %ile personal exposure results %ile personal exposure results

3030

Page 31: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

SummarySummary

3131

Limited sampling results analysis of the selected unit operations Limited sampling results analysis of the selected unit operations identified:identified:– Personal exposure levels likely to occurPersonal exposure levels likely to occur

Additional data analysis and professional judgement would assist in Additional data analysis and professional judgement would assist in implementing controls and work-practices that would reduce implementing controls and work-practices that would reduce exposure below target levelsexposure below target levels

Add required data collection Add required data collection – Sample weightSample weight– Name/brand name/picture of controlsName/brand name/picture of controls

Page 32: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Summary Summary

PPE and RPE are standardized across all pharma sites for PPE and RPE are standardized across all pharma sites for some companiessome companies– Same approach is needed for pharma containment Same approach is needed for pharma containment

equipment also equipment also Installation of equipment is not enough; SOPs, training Installation of equipment is not enough; SOPs, training

and maintenance are even more critical and maintenance are even more critical Participate in exposure control selection processParticipate in exposure control selection process

3232

Page 33: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Plans Plans

Invite IHs from other companies and form a group Invite IHs from other companies and form a group Conduct similar data analyses with larger sample sizeConduct similar data analyses with larger sample size Address lessons learned from this limited study Address lessons learned from this limited study

– Weight rangeWeight range– Specific details on engineering controls Specific details on engineering controls

Peer reviewPeer review PublishPublish

3333

Page 34: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Recognition Recognition

Terry Lane from Merck for reviewTerry Lane from Merck for review Perry Logan for insights on analysis using BDA toolPerry Logan for insights on analysis using BDA tool Current and previous ISS team who diligently conducted Current and previous ISS team who diligently conducted

exposure monitoring exposure monitoring Ankit Sharma, Gopal and Prasanth from ISS who Ankit Sharma, Gopal and Prasanth from ISS who

complied and summarized results complied and summarized results

3434

Page 35: Pharma forum 2016 by Maharshi Mehta

www.issehs.com

Volunteers participate in Volunteers participate in rigorous study? Publication of rigorous study? Publication of papers? papers?

Thank you Thank you

3535


Recommended